Adicet Bio, Inc. (ACET)

Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $61.14 million. The enterprise value is -$48.71 million.

Market Cap	61.14M
Enterprise Value	-48.71M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Adicet Bio has 83.25 million shares outstanding. The number of shares has increased by 42.22% in one year.

Current Share Class	83.25M
Shares Outstanding	83.25M
Shares Change (YoY)	+42.22%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	1.66%
Owned by Institutions (%)	38.11%
Float	61.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.45
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.48, with a Debt / Equity ratio of 0.12.

Current Ratio	7.48
Quick Ratio	7.32
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-63,086.50

Financial Efficiency

Return on equity (ROE) is -64.39% and return on invested capital (ROIC) is -39.14%.

Return on Equity (ROE)	-64.39%
Return on Assets (ROA)	-36.52%
Return on Invested Capital (ROIC)	-39.14%
Return on Capital Employed (ROCE)	-86.48%
Revenue Per Employee	n/a
Profits Per Employee	-$780,500
Employee Count	152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.70% in the last 52 weeks. The beta is 1.61, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-49.70%
50-Day Moving Average	0.70
200-Day Moving Average	0.80
Relative Strength Index (RSI)	53.85
Average Volume (20 Days)	686,074

Short Selling Information

The latest short interest is 4.46 million, so 5.36% of the outstanding shares have been sold short.

Short Interest	4.46M
Short Previous Month	4.03M
Short % of Shares Out	5.36%
Short % of Float	7.20%
Short Ratio (days to cover)	8.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-126.17M
Pretax Income	-139.79M
Net Income	-118.64M
EBITDA	-119.62M
EBIT	-126.17M
Earnings Per Share (EPS)	-$1.30

Balance Sheet

The company has $124.96 million in cash and $15.36 million in debt, giving a net cash position of $109.61 million or $1.32 per share.

Cash & Cash Equivalents	124.96M
Total Debt	15.36M
Net Cash	109.61M
Net Cash Per Share	$1.32
Equity (Book Value)	133.37M
Book Value Per Share	1.60
Working Capital	110.66M

Cash Flow

In the last 12 months, operating cash flow was -$98.14 million and capital expenditures -$2.12 million, giving a free cash flow of -$100.25 million.

Operating Cash Flow	-98.14M
Capital Expenditures	-2.12M
Free Cash Flow	-100.25M
FCF Per Share	-$1.20

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.22%
Shareholder Yield	-42.22%
Earnings Yield	-194.83%
FCF Yield	-164.64%

Analyst Forecast

The average price target for Adicet Bio is $5.60, which is 662.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.60
Price Target Difference	662.53%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-58.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1